CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to test the safety and effectiveness of the study drug datopotamab deruxtecan in participants with metastatic breast...
Phase 2
Boston, Massachusetts, United States and 2 other locations
study drug, Nivolumab as a possible treatment for triple-negative breast cancer that has spread to other parts of the body.The inte...
Phase 2
Boston, Massachusetts, United States and 9 other locations
This research study is studying a combination of drugs as a possible treatment for breast cancer with a BRCA mutation.The intervent...
Phase 1
Boston, Massachusetts, United States and 1 other location
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...
Phase 2
Boston, Massachusetts, United States and 7 other locations
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...
Phase 2
Boston, Massachusetts, United States and 3 other locations
Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer.The names of the study drugs used in this research ...
Phase 2
Boston, Massachusetts, United States and 3 other locations
This research study is studying a drug called GDC-0084 as a possible treatment for HER2-Positive Breast Cancer.The drugs involved i...
Phase 2
Boston, Massachusetts, United States
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Boston, Massachusetts, United States and 19 other locations
This research study is studying a drug as a possible treatment for ER-positive Breast CancerThe drug involved in this study is:-Rib...
Phase 2
Boston, Massachusetts, United States and 2 other locations
This research study is studying a drug combination of nivolumab and ipilimumab as a possible treatment for hypermutated HER2 negative breast ...
Phase 2
Boston, Massachusetts, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal